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Abstract
Background: Leishmania braziliensis is the main causative agent of cutaneous leishmaniasis in Brazil. Protection against
infection is related to development of Th1 responses, but the mechanisms that mediate susceptibility are still poorly
understood. Murine models have been the most important tools in understanding the immunopathogenesis of L. major
infection and have shown that Th2 responses favor parasite survival. In contrast, L. braziliensis–infected mice develop strong
Th1 responses and easily resolve the infection, thus making the study of factors affecting susceptibility to this parasite
difficult.
Methodology/Principal Findings: Here, we describe an experimental model for the evaluation of the mechanisms
mediating susceptibility to L. braziliensis infection. BALB/c mice were inoculated with stationary phase promastigotes of L.
braziliensis, isolates LTCP393(R) and LTCP15171(S), which are resistant and susceptible to antimony and nitric oxide (NO),
respectively. Mice inoculated with LTCP393(R) presented larger lesions that healed more slowly and contained higher
parasite loads than lesions caused by LTCP15171(S). Inflammatory infiltrates in the lesions and production of IFN-c, TNF-a,
IL-10 and TGF-b were similar in mice inoculated with either isolate, indicating that these factors did not contribute to the
different disease manifestations observed. In contrast, IL-4 production was strongly increased in LTCP393(R)-inoculated
animals and also arginase I (Arg I) expression. Moreover, anti-IL-4 monoclonal antibody (mAb) treatment resulted in
decreased lesion thickness and parasite burden in animals inoculated with LTCP393(R), but not in those inoculated with
LTCP15171(S).
Conclusion/Significance: We conclude that the ability of L. braziliensis isolates to induce Th2 responses affects the
susceptibility to infection with these isolates and contributes to the increased virulence and severity of disease associated
with them. Since these data reflect what happens in human infection, this model could be useful to study the pathogenesis
of the L. braziliensis infection, as well as to design new strategies of therapeutic intervention.
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Introduction
Leishmaniasis comprises several diseases caused by protozoans
of the genus Leishmania. The most common disease in Brazil is
American tegumentary leishmaniasis (ATL), caused by L.
braziliensis. In the Americas, the main invertebrate vectors for this
parasite, are sand flies of the genus Lutzomyia [1]. The most studied
parasite of the genus Leishmania is L. major. Human infection with
this pathogen is generally benign and eventually resolves
spontaneously, resulting in lifelong immunity. On the other hand,
infection with L. braziliensis is chronic and causes latency, which
may lead to parasite dissemination to the nasal and oral mucosa
years after resolution. Even chemotherapeutic treatment does not
exclude the possibility of developing mucocutaneous leishmaniasis
[2–4].
Protection against, and susceptibility to L. major, another
cutaneous leishmaniasis-causing parasite, have been clearly
established in mouse models of infection. In mice, Th1 responses
[5] involving nitric oxide (NO), and the cytokines IL-12, IFN-c
and TNF-a [6,7], result in parasite killing [8,9]. In contrast, Th2
responses, which are characterized by the production of IL-4, IL-
13 and IL-10, result in susceptibility to infection [10-13].
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CD4+CD25+ regulatory T cells are also important sources of IL-10
and contribute significantly to susceptibility [14,15]. Similarly,
Th1 responses have been shown to be necessary for parasite killing
in mouse models of L. braziliensis infection [16]; however, it has
been difficult to develop experimental models for studying
susceptibility factors because most mouse strain develop strong
Th1 responses that easily control L. braziliensis infection [17]. In
humans, cutaneous (CL) and mucocutaneous leishmaniasis (ML)
caused by L. braziliensis infection are also associated with a strong
production of Th1 cytokines and marked migration of inflamma-
tory mononuclear cells to lesion sites [18–22]; although sponta-
neous resolution is observed in only 30% of patients [23]. Also a
large range of clinical manifestations is observed in patients with L.
braziliensis cutaneous leishmaniasis, showing a great difference
between the diseases caused by L. major and L. braziliensis. A
complex interplay between host traits and intrinsic properties of
the parasite L. braziliensis that contribute to the variety of clinical
presentations is not clearly understood. Experimental infection of
mice with two L. braziliensis isolates from patients with either mild
or severe lesions resulted in distinct clinical features and different
patterns of chemokine production; however, no differences were
observed in parasite replication [24,25]. Intrinsic characteristics of
the parasites that result in increased capacity to survive inside
human macrophages, such as resistance to nitric oxide (NO) in
some L. braziliensis and L. amazonensis isolates, have been associated
with more severe forms of the disease [26]. Despite these findings,
the true immunological mechanisms that mediate susceptibility to
L. braziliensis remain poorly understood.
To address this issue, we developed an experimental model in
which BALB/c mice were inoculated with stationary phase
promastigotes from L. braziliensis isolates obtained from CL
patients that were refractory or responsive to antimony treatment,
and that presented different severities of disease manifestations.
We characterized the experimental infection with these two
isolates in mice and found that similar to the difference in disease
severity between the human hosts from which these strains were
isolated, the resistant isolate caused a more severe disease in mice
than the susceptible isolate. The increased lesion development
caused by increased parasitic replication was associated with the
production of IL-4 in response to the resistant isolate. This
interesting model of infection can be useful to further studies to
understand the variability of clinical manifestations of the disease




Female 6–8 week old BALB/c mice were used in all
experiments. The animals were maintained at the animal holding
facility of the department of Biochemistry and Immunology of the
Ribeira˜o Preto Medical School – University of Sa˜o Paulo, and all
procedures were approved by the local ethics committee for
animal care and research ‘‘Ethics Committee in Animal Research
of the FMRP-USP’’. Leishmania braziliensis isolates LTCP393(R)
and LTCP15171(S) were obtained from cutaneous ulcers of
patients from the endemic area of Corte de Pedra, BA, Brazil,
specifically for this study, and all human subjects were briefed on
procedures and signed informed consent documentation. All
work with human subjects was carried out under ‘‘Federal
University of Bahia Ethical Committee’’ approval number 5/
2006. L. braziliensis LTCP15171(S) was isolated from a 38-year-
old male patient who had a single skin ulcer with an area of
120 mm2 that was cured after one course of antimony therapy. L.
braziliensis LTCP393(R) was isolated from a 26-year-old male
patient that had several skin lesions ranging in size from 100 to
1575 mm2 and mucosal disease. This patient was treated with
several courses of antimony, pentoxifylin, and amphotericin B
over a period of 20 years before being cured. These parasites
were isolated in N.N.N. media and frozen in liquid nitrogen
immediately after isolation.
Parasite Characterization
Promastigotes were grown in Schneider’s insect medium
(Sigma, Saint Louis, USA) supplemented with 20% heat-
inactivated fetal calf serum (Cultilab, Campinas, SP, Brazil),
4 mM NaHCO3, 100 U/ml penicillin, 100 mg/ml streptomycin
(all from Gibco, Grand Island, NY, USA), and 2% v/v male
human urine at 25uC. At 5th day of culture, both isolates reached
stationary phase, after inoculation of 16106 promastigotes in
6 ml of medium. The amount of metacyclic parasites at the
chosen day was analyzed using Ficoll 400 (Pharmacia-GE
Healthcare, Uppsala, Sweden) gradient as described [27,28],
and was similar for LTCP393(R) and LTCP15171(S) isolates
(0.8050%60.01528 and 1.132%60.2122, respectively). NO
resistance assays were performed as described [26,29].
LTCP393(R) was resistant to 16 mM NaNO2 (NO donor), and
LTCP15171(S) was susceptible to 4 mM NaNO2. Antimony
resistance was tested by culturing BALB/c mice peritoneal
macrophages isolated and cultured as described [30], in the
presence or absence of 10, 30 and 90 mg/ml Glucantime (Sanofi
Aventis Farmaceˆutica, Suzano,SP, Brazil), for 24, 48 and 72 h.
Compared to non-treated infected cells, only in LTCP15171(S)-
infected macrophages there was a substantial reduction in
intracellular parasite numbers. We therefore will refer to these
parasites as resistant to antimony and NO (LTCP393(R)), and
susceptible to antimony and NO (LTCP15171(S)). To determine
the infectivity of the isolates, macrophages were incubated with 5
and 10 parasites per cell and the percentage of infected cell and
number of intracellular parasites determined. Before the
beginning of the experiments, the isolates were submitted to
passages into hamsters and BALB/c mice, for recovering of
Author Summary
Leishmaniasis is a neglected disease that affects more than
12 million people worldwide. In Brazil, the cutaneous
disease is more prevalent with about 28,000 new cases
reported each year, and L. braziliensis is the main causative
agent. The interesting data about the infection with this
parasite is the wide variety of clinical manifestations that
ranges from single ulcerated lesions to mucocutaneous
and disseminated disease. However, experimental models
to study the infection with this parasite are difficult to
develop due to high resistance of most mouse strains to
the infection, and the mechanisms underlying the distinct
manifestations remain poorly understood. Here, the
authors use a mouse experimental model of infection
with different L. braziliensis isolates, known to induce
diseases with distinct severity in the human hosts, to
elucidate immune mechanisms that may be involved in
the different manifestations. They showed that distinct
parasite isolates may modulate host response, and
increased IL-4 production and Arg I expression was related
to more severe disease, resulting in longer length of
disease with larger lesions and reduced parasite clearance.
These findings may be useful in the identification of
immunological targets to control L. braziliensis infection
and potential clinical markers of disease progression.
IL-4 and Susceptibility to L. braziliensis
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virulence and selection of parasites. During the experiments,
parasite virulence was assured by constant maintenance and re-
isolation from infected BALB/c mice.
Parasite inoculation, lesion measurement and parasite
load estimate
We used a well established protocol of inoculation [31–35], in
which the right ear dermis of BALB/c mice was inoculated with
stationary phase promastigotes (106 parasites in 10 ml of sterile
saline) using a 27.5-gauge needle. Lesion size, which was defined
as the difference in thickness between the infected ear and the non-
infected contralateral ear, was monitored weekly using a digital
caliper (Mitutoyo, Suzano, SP, Brazil). The parasite load was
determined using a quantitative limiting dilution assay as
previously described [36].
Antibody treatment
The rat anti-IL-4 mAb was purified from ascites of mice
injected with the hybridoma 11B11. IL-4 was neutralized by
intraperitoneal (i.p.) injection of 2 mg purified mAb one day
before infection. Additional i.p. injections of 1 mg purified mAb
were performed twice a week for seven weeks. Controls received
1 mg of normal rat IgG diluted in PBS.
Cell isolation from lesions and lymph nodes
Ears from infected mice were collected and incubated at 37uC
for one hour in RPMI-1640 medium containing 2 mM L-
glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin (all from
Gibco) and 500 mg/ml Liberase CI (Roche, Basel, Switzerland).
The tissues were processed inside Medcons using a Medimachine
(both from Becton & Dickinson Biosciences, San Diego, CA,
USA). After processing, the cells were filtered through a 50 mm
filter, viability was assessed by trypan blue exclusion, and the cell
concentration was adjusted.
Flow cytometry
Immunostaining was performed with anti-CD3, CD19, CD4,
CD8, CD25, CD11b, CD11c and Gr1 antibodies conjugated to
FITC, PE or PerCP fluorochromes. For regulatory T cell
phenotyping, CD4+CD25+ cells were stained with anti-FoxP3,
CD103, CTLA-4 and GITR antibodies conjugated to PE. For
intracellular staining, the cells were permeabilized with a
Cytofix/Cytoperm kit (BD Biosciences) according to the
manufacturer’s guide. For all analyses, the results were compared
to those obtained with cells stained with isotype control
antibodies (all antibodies were from BD Biosciences and
eBiosciences, San Diego, CA, USA). Cell acquisition was
performed using a FACSort flow cytometer and CellQuest
software (BD Biosciences). Data were plotted and analyzed using
Cell Quest (BD Biosciences) and FlowJo software (Tree Star,
Ashland, OR).
Cell cultures
Single cell suspensions of draining retromaxilar lymph nodes
were prepared aseptically, diluted to a concentration of
26106 cells/ml and dispensed into 48-well plates in a total volume
of 500 ml of complete RPMI-1640 medium (Gibco) (16106 cells/
well) with or without live stationary phase L. braziliensis
promastigotes at a ratio of five parasites to one cell (56106 par-
asites/well). Cell culture supernatants were harvested after 72 h of
culture at 37uC in 5% CO2, and the levels of IFN-c, IL-4, IL-10
and TGF-b were determined by ELISA using commercial kits (BD
Biosciences and R&D Systems, Minneapolis, MN, USA).
Real time PCR
Total RNA was extracted from whole fragments of infected ears
using the Promega RNA extraction kit (Promega, Madison, WI,
USA). RNA was quantified using a spectrophotometer (BioMate 3;
Thermo Spectronic, Rochester, NY, USA) and cDNA was
synthesized using 1 mg RNA through an RT reaction using
ImProm-II reagents (Promega) according to the manufacturer’s
instructions. Real-time PCR quantitative mRNA analyses were
performed using the Platinum SYBR Green qPCR SuperMix-
UDG with ROX reagents (Invitrogen, Carlsbad, CA, USA) and
the ABI Prism 7000 sequence detection system (Applied
Biosystems, Warrington, UK). The sequences of murine primers
were designed using PrimerExpress software (Applied Biosystems)
and nucleotide sequences present in the GenBank database.
Relative gene expression levels were calculated according to the
instructions from the Applied Biosystems user’s bulletin (P/N
4303859). Briefly, gene expression levels were normalized to the
level of b-actin in each sample using the cycle threshold (Ct)
method. Negative controls without RNA and without RT were
also performed. The threshold for positivity of real-time PCR was
determined based on the expression of the specific mRNAs in the
ears of uninfected mice using the equation 22DDCt. Murine primer
sequences utilized: b-actin sense: 59- AGC TGC GTT TTA CAC
CCT TT - 39, b actin anti-sense: 59 - AAG CCA TGC CAA TGT
TGT CT – 39; IFN-c sense: 59- GCA TCT TGG CTT TGC
AGC T – 39, IFN-c anti-sense: 59 - CCT TTT TCG CCT TGC
TGT TG – 39; IL-4 sense: 59 - GAA TGT ACC AGG AGC CAT
ATC – 39, IL-4 anti-sense: 59 - CTC AGT ACT ACG AGT AAT
CCA – 39; IL-10 sense: 59 - TGG ACA ACA TAC TGC TAA
CCG – 39, IL-10 anti-sense: 59 - GGA TCA TTT CCG ATA
AGG CT – 39; TGF-b sense: 59 - GCT GAA CCA AGG AGA
CGG AAT – 39, TGF-b anti-sense: 59 - GCT GAT CCC GTT
GAT TTC CA – 39; TNF-a sense: 59 - TGT GCT CAG AGC
TTT CAA CAA - 39, TNF-a anti-sense: 59 - CTT GAT GGT
GGT GCA TGA GA – 39; inducible nitric oxide synthase (iNOS)
sense: 59 - CGA AAC GCT YCA CTT CCA A – 39, iNOS anti-
sense: 59 - TGA GCC TAT ATT GCT GTG GCT – 39; arginase
I (Arg I) sense: 59 - GTT CCC AGA TGT ACC AGG ATT C –
39, Arg I anti-sense: 59 - CGA TGT CTT TGG CAG ATA TGC
– 39. Murine Arg I primer was tested for cross-hybridization with
the parasite ortholog, and no cross-hybridization or amplification
occurred in the parasite material.
Statistical analyses
Data were expressed as means 6 standard errors of the means
(SEM). Student’s t test and ANOVA followed by Tukey’s multiple
comparison test were used to analyze the statistical significance of
the observed differences between the mice infected with
LTCP393(R) or LTCP15171(S) when samples had a normal
distribution, and Mann-Whitney tests were used when the
distribution was not normal. Differences were considered
significant when P,0.05. All analyses were performed using
Prism software version 5.0 (GraphPad San Diego, CA, USA).
Results
Pattern of experimental infection with LTCP393(R) and
LTCP15171(S) in BALB/c mice
To examine the kinetics of lesion development, 5th day of
culture stationary phase parasites, with similar amount of
metacyclics, were inoculated in the right ear dermis of BALB/c
mice, and lesions were measured weekly using a caliper for 15
weeks following infection.
IL-4 and Susceptibility to L. braziliensis
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Mice controlled the lesions caused by both isolates, but kinetics
of lesion development was different between the groups and the
severity of lesions was higher in LTCP393(R)-infected mice.
Fifteen weeks after infection, the lesions in mice inoculated with
LTCP15171(S) were completely healed, while small lesions still
remained in mice inoculated with LTCP393(R) (Fig. 1A). On the
third week after infection, the lesions in animals inoculated with
LTCP15171(S) were approximately twice the size of those in mice
inoculated with LTCP393(R) (Fig. 1A and 2B). Five weeks post-
infection, the lesions in the animals inoculated with LTCP15171(S)
reached their peak size and began to decrease in thickness, while
the lesions in mice infected with LTCP393(R) continued to
develop and reached their peak size seven weeks post-infection. At
this time point, the lesions in mice inoculated with LTCP393(R)
were approximately three times thicker than those in mice
inoculated with LTCP15171(S) and two times thicker than the
peak size of the lesions in mice inoculated with LTCP15171(S),
which was reached five weeks post-infection (Fig. 1A). Also in this
time point, the lesions were ulcerated in the mice inoculated with
LTCP393(R) (Fig. 1B, arrow). Eight weeks post-infection, the
lesions in mice inoculated with the LTCP393(R) isolate began to
regress, but these lesions remained significantly larger than those
in mice inoculated with LTCP15171(S), and small lesions were
present in mice inoculated with LTCP393(R) after 12 weeks
(Fig. 1B, arrowhead).
We next determined the infective capacity of the stationary
phase promastigotes of both isolates, by quantifying the amount of
amastigotes inside mouse peritoneal macrophages, after 6 h
incubation. LTCP393(R) and LTCP15171(S) parasites infected
57.14%69.787 and 58.38%65.558 the cells, respectively. More-
over, the amount of intracellular parasites was similar
(347.7647.75 versus 384.7620.30 amastigotes of the isolates
LTCP393(R) and LTCP15171(S), respectively, per 100 macro-
phages, using 5 parasites/cell to the infection). Similar data was
found using different ratio of parasites/cell. We concluded that
both isolates infect macrophages with the same efficacy.
The number of parasites in the infected ears and in the draining
lymph nodes at specific time points post-infection was determined
using a previously described limiting dilution assay [36]. The
parasite loads in the earlier phases of the experimental infection
were analyzed (1, 3, 7 and 14 days post-infection) in ears and
draining lymph nodes. Therefore, no difference was found
between the groups, showing that in vivo, as observed previously
in vitro, both parasite isolates presented the same infectivity rate
with the chosen inocula. At time points three and five weeks post-
infection, also no differences in parasite load were observed
between the groups. Seven weeks post-infection, a significantly
higher number of parasites was present in the ears of mice
inoculated with LTCP393(R) than those of mice inoculated with
LTCP15171(S) (2.01610861.636108 and 1.73610461.16104,
respectively; p = 0.0079). Twelve weeks after infection, no parasites
were detected in the ears of animals inoculated with the susceptible
isolate, but the ears of mice inoculated with the resistant isolate
contained an average of 1.79610761.086107 parasites (Fig. 2A).
Fewer parasites were detected in the draining lymph nodes than
in the ears of infected mice. Three weeks post-infection, the
number of parasites detected in the lymph nodes of mice
inoculated with LTCP15171(S) was significantly higher than that
Figure 1. LTCP393(R)-inoculated BALB/c mice present larger lesions. (A) The animals were inoculated with 16106 Leishmania braziliensis
stationary phase promastigotes, isolates LTCP393(R) (black squares) or LTCP15171(S) (white squares) in the right ear dermis and the course of lesion
development was monitored for 15 weeks. Lesion thickness was determined as the difference between the infected ear and the contralateral one,
noninfected. Results are expressed as mean 6 standard error of mean, and are representative of 2–3 independent experiments. (B) Photographs of
mouse ears at 3, 5, 7 and 12 weeks post infection (w.p.i.). The arrow indicates ulceration in the ear of an animal infected with LTCP393(R) isolate at 7
weeks post infection, and the arrowhead indicates remaining lesion at 12 weeks post infection in animals infected with LTCP393(R) isolate. *p,0,05.
doi:10.1371/journal.pntd.0000965.g001
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in lymph nodes of mice inoculated with LTCP393(R)
(103.7645.94 and 0, respectively). Five weeks after infection, no
significant difference was observed between the number of
parasites in lymph nodes from mice inoculated with LTCP393(R)
(70.53643.47) and that in lymph nodes from mice inoculated with
LTCP15171(S) (61.32627.55). Despite the regression of lesions in
the ears at subsequent time points post-infection, the parasite loads
in the lymph nodes increased significantly (LTCP393(R),
p = 0.0112 and p = 0.0398 at seven and 12 weeks post-infection,
respectively, compared to five weeks post-infection;
LTCP15171(S), p = 0.0119 and p = 0.0080 at seven and 12 weeks
post-infection, respectively, compared to five weeks post-infection);
however, no significant differences in parasite loads were detected
between mice inoculated with the resistant or susceptible isolates
(Fig. 2B). We next characterized the inflammatory infiltrates
present in the lesions of mice experimentally infected with each
isolate using flow cytometry. There were no differences in the cell
populations studied three weeks after infection (Fig. 3A). Five
weeks after infection, the numbers of most cell types, and
especially of the CD4+ T lymphocytes and neutrophils (GR-1+),
increased significantly in infiltrates in mice infected with either
isolate; however, CD8+ T lymphocytes, dendritic cells
(CD11b+CD11c+) and macrophages (CD11b+CD11c2) were not
significantly increased in infiltrates in LTCP15171(S)-inoculated
mice. No differences in the cell populations were detected between
mice infected with resistant or susceptible isolates at this time point
(Fig. 3B).
Seven weeks after infection, more B lymphocytes were present
in lesions of animals inoculated with LTCP393(R) than in those of
animals inoculated with LTCP15171(S) (102,300627,840 and
18,44063,189, respectively; p = 0.0201). Similarly, the lesions of
mice experimentally infected with LTCP393(R) contained more
CD4+ T lymphocytes than those of mice experimentally infected
with LTCP15171(S) (1,761,0006257,100 vs. 990,9006124,200;
p = 0.0279) (Fig. 3C). No differences were observed in the number
of CD8+ T lymphocytes or CD4+CD25+ T cells in the lesions of
mice inoculated with LTCP393(R) or LTCP15171(S), and
CD4+CD25+ T cells expressed similar levels of FoxP3, CD103,
CTLA-4 and GITR in both groups (Fig. 3E). The numbers of
neutrophils, dendritic cells (CD11b+CD11c+) and macrophages
were higher in animals inoculated with LTCP393(R) than in
animals inoculated with LTCP15171(S) (p = 0.0086, 0.0339 and
0.0006, respectively); between weeks five and seven, these cell
types decreased in number more intensely in lesions from mice
inoculated with LTCP15171(S) than in lesions from mice
inoculated with LTCP393(R) (Fig. 3C).
Twelve weeks post-infection, the numbers of all cell populations
in the animals inoculated with LTCP393(R) remained similar to
those observed seven weeks post-infection while the numbers of
most cell populations decreased in the animals inoculated with
LTCP15171(S). The numbers of B lymphocytes, CD4+ and CD8+
T lymphocytes, CD4+CD25+ T cells, and neutrophils were thus
significantly higher in animals inoculated with LTCP393(R) than
in LTCP15171(S)-inoculated mice. No statistical differences in the
numbers of dendritic cells and macrophages were observed
between mice inoculated with resistant or susceptible isolates
(Fig. 3D). Furthermore, no significant difference was observed in
the frequency (%) of FoxP3, CD103, GITR and CTLA-4 positive
cells among CD4+CD25+ cells between mice inoculated with the
resistant or susceptible isolates (Fig. 3F).
Lymph node cells from mice inoculated with LTCP393(R)
produce higher levels of IL-4 when challenged with the
parasite
We have previously observed that the differences between the
disease manifestations in mice inoculated with LTCP393(R) or
LTCP15171(S) became evident at later time points of the
experimental infection. Therefore, immune responses induced by
parasites were examined by measuring the cytokines produced by
lymph node cells isolated 3–12 weeks post-infection and stimulated
in vitro with live stationary phase promastigotes. The average
production of IFN-c was higher in lymph node cells harvested
from animals inoculated with LTCP15171(S) three weeks post-
infection, than in those from animals inoculated with
LTCP393(R); however, this difference was not statistically
significant. Lymph node cells harvested from animals inoculated
with either isolate 5, 7 or 12 weeks post-infection produced more
than 5 ng/ml IFN-c when stimulated with live parasites. No
statistical significant differences were observed between lymph
node cells from mice inoculated with resistant or susceptible
isolates at these time points (Fig. 4A).
Low levels of IL-4 were produced by lymph node cells isolated
from animals inoculated with LTCP15171(S) three weeks post-
infection and stimulated with live parasites, but no IL-4 was
detected in the lymph node cells from animals inoculated with
Figure 2. LTCP393(R)-inoculated BALB/c mice present higher
parasite loads in the lesion sites. Parasite load estimate in ears (A)
and lymph nodes (B) of BALB/c mice inoculated at right ear dermis with
16106 stationary phase promastigotes of L. braziliensis, isolates
LTCP393(R) (black bars) or LTCP15171(S) (white bars), at 3, 5, 7 and
12 weeks post infection. Results are expressed as mean 6 standard
error of mean, and are representative of 3 independent experiments.
n.d. = non-detected. *p,0,05.
doi:10.1371/journal.pntd.0000965.g002
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LTCP393(R) at this time point. In contrast, five weeks post-
infection, lymph node cells isolated from animals inoculated with
LTCP393(R) and challenged with live parasites produced
significantly higher levels of IL-4 (3.98760.1914 ng/ml) than
those isolated from animals inoculated with LTCP15171(S)
(0.212260.0924 ng/ml; p,0.0001). The production of IL-4 by
lymph node cells from mice inoculated with the resistant isolate
seven and 12 weeks post-infection was lower than that observed at
five weeks post-infection (1.40660.2616 and 0.653660.08217 ng/
ml, respectively), but still significantly higher than that observed in
animals inoculated with the susceptible parasites (0.13560.04826
and 0.107160.04127 ng/ml; p = 0.0088 and 0.0040, respectively)
(Fig. 4B).
Upon stimulation with parasites, IL-10 was detected at low
levels in lymph node cells isolated from mice inoculated with either
isolate three and five weeks post-infection. Seven weeks after
infection, however, IL-10 production increased in cells isolated
from mice inoculated with LTCP393(R), and these cells produced
higher levels of IL-10 than those isolated from mice inoculated
with the susceptible parasite (0.491160.07603 and
0.192560.02022 ng/ml, respectively; p = 0.028). Twelve weeks
post-infection, IL-10 production increased in lymph node cells
from mice inoculated with either isolate, but cells from mice
inoculated with LTCP393(R) continued to produce higher levels
of this cytokine than those from mice inoculated with
LTCP15171(S) (2.19060.1237 ng/ml and 1.48860.1190 ng/ml,
respectively; p = 0.0064) (Fig. 4C). TGF-b production did not
significantly differ between stimulated and unstimulated cultures
or between cells isolated from mice inoculated with LTCP393(R)
and those from mice inoculated with LTCP15171(S) at the time
points analyzed. The production of this cytokine throughout the
experimental infection remained similar to non-infected mice in all
time points analyzed in both groups (Fig. 4D).
Mice inoculated with LTCP393(R) have increased
expression of IL-4 and Arg I in the lesions
The expression patterns of cytokines and the enzymes iNOS
and Arg I at the sites of experimental infection, were examined by
processing the ears of the experimentally infected mice for mRNA
extraction and quantifying mRNA by real time PCR at the same
time points at which cytokine production was measured in lymph
node cells. Three weeks post-infection, there was no significant
difference in the expression of IFN-c, IL-4, IL-10, TGF-b, TNF-a,
iNOS and Arg I mRNA at experimental infection sites between
the mice inoculated with the resistant or susceptible parasites
(Fig. 5A–G). Similar to our observations in lymph node cultures,
five weeks post-infection, the ears of LTCP393(R)-inoculated mice
expressed higher levels of IL-4 mRNA than those of
LTCP15171(S)-inoculated mice (372.66168.1 and 43.51620.81;
p = 0.0398) (Fig. 5B), and no significant differences were found in
the expression of IFN-c mRNA (Fig. 5A). No differences were
found in IL-10 and TGF-b expression and also in the enzymes
iNOS and Arg I expression, at five weeks post infection (Fig. 5C–
G). At this same time point, TNF-a was expressed at higher levels
in the ears of animals inoculated with LTCP393(R) than those of
animals inoculated with LTCP15171(S) (Fig. 5E). Seven weeks
post-infection, we observed approximately 20-fold increase in IL-4
mRNA expression in mice inoculated with the resistant isolate
compared to that in mice inoculated with the susceptible isolate
(419.9676.33 and 16.2365.164, respectively; p = 0.0019) (Fig. 5B).
Also, Arg I expression was significantly higher in ears of mice
experimentally infected with LTCP393(R) compared to mice
Figure 3. Flow cytometry of infected BALB/c mice ears inflammatory infiltrate. The animals were inoculated with 16106 stationary phase L.
braziliensis promastigotes, isolates LTCP393(R) (black bars) or LTCP15171(S) (white bars). Analyses were conducted at 3, 5, 7 and 12 weeks post
infection, FoxP3, CD103, CTLA-4 and GITR expression on CD4+CD25+ cells were evaluated at 7 and 12 weeks post infection. Results are expressed as
total number of cells in the lesion (A, B, C and D), and as percentage of cells inside CD4+CD25+ gate (E and F). Results are expressed as mean 6
standard error of mean, and are representative of 3 independent experiments. *p,0,05.
doi:10.1371/journal.pntd.0000965.g003
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infected with LTCP15171(S) (21.4165.615 and 3.28261.338,
respectively; p = 0.02) (Fig. 5G). No statistical difference was
detected in IFN-c and iNOS expression between these groups,
although a clear tendency of higher expression of the enzyme was
observed in ears of mice infected with the resistant isolate (Fig. 5A
and F). Albeit IL-10 mRNA expression increased in the ears of
animals infected with the LTCP393(R) isolate at seven weeks post
infection, it was not significantly different from that detected in the
ears of LTCP15171(S)-inoculated mice. (Fig. 5D). No differences
were detected in the expression of TNF-a and TGF-b seven weeks
after infection (Fig. 5B and E). Twelve weeks post-infection, the
expression levels of IFN-c, IL-4, IL-10, TNF-a and Arg I were
similar in both groups. The only differences observed were in
TGF-b and iNOS expression; the cytokine was expressed at higher
levels in ears of mice inoculated with LTCP15171(S) while the
enzyme was expressed at higher levels in ears of mice inoculated
with LTCP393(R) (Fig. 5E and F).
IL-4 neutralization decreases lesion development and
parasite load in animals experimentally infected with
LTCP393(R)
Because the most striking difference between the two groups
was the level of IL-4 production, it was reasonable to associate IL-
4 production with the increased susceptibility to experimental
infection with the resistant isolate. To test this hypothesis, BALB/c
mice were treated with anti-IL-4 mAb before the inoculation with
16106 stationary phase promastigotes of L. braziliensis
LTCP393(R) or LTCP15171(S) isolates. The mice were then
treated with anti-IL-4 mAb twice a week for seven weeks after
infection. During the first six weeks after infection, no differences
were detected between mice inoculated with LTCP393(R) and
treated with anti-IL-4 mAb and those inoculated with
LTCP393(R) and treated with control IgG. Seven weeks after
experimental infection, however, lesions in animals treated only
with normal IgG increased in thickness while those in animals
treated with anti-IL-4 mAb began to decrease significantly in
thickness (0.823360.151 and 0.3560.02, respectively; p = 0.036)
(Fig. 6A). In mice inoculated with LTCP15171(S), no difference
was observed between the control animals and those treated with
the anti-IL-4 mAb at any time point following inoculation of
parasites (Fig. 6B). Moreover, the depletion of IL-4 in animals
inoculated with LTCP393(R) resulted in lesion development
similar to that seen in mice inoculated with LTCP15171(S), in
which little production of IL-4 was detected. Quantification of the
parasite load showed that anti-IL-4 mAb treatment resulted in not
only decreased lesion thickness, but also a significant decrease in
the parasite loads (,1006) in the ears of LTCP393(R)-inoculated
animals. As observed in the lesion measurements, parasite load in
anti-IL-4 treated LTCP393(R)-inoculated mice ears was similar to
that observed in LTCP15171(S)-inoculated mice (Fig. 7A).
Although the average of parasite loads in lymph nodes of anti-
IL-4 mAb treated LTCP393(R)-inoculated mice were lower
compared to rat IgG treated counterparts, no significant difference
Figure 4. Cytokine production by lymph node cells from LTCP393(R) and LTCP15171(S)-inoculated mice. Cells were isolated from the
draining lymph nodes of non infected (N.I.) BALB/c mice or BALB/c mice inoculated with 16106 stationary phase L. braziliensis promastigotes, isolates
LTCP393(R) (black bars) or LTCP15171(S) (white bars), at 3, 5, 7 and 12 weeks post infection. 16106 cells/well were incubated in 48 flat bottom well
plates with 500 ml of complete RPMI medium for 72 hours, at 37uC, 5% CO2, in the presence of live parasites in a 5:1 parasite:cell ratio. The cell
cultures supernatants were collected and IFN-c (A), IL-4 (B), IL-10 (C) and TGF-b (D) productions were quantified by ELISA method. Results are
expressed as mean 6 standard error of mean, and are representative of 3 independent experiments. n.d. = non-detected. *p,0,05.
doi:10.1371/journal.pntd.0000965.g004
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was observed (Fig. 7B). In mice inoculated with LTCP15171(S), no
difference in lymph node parasite loads were observed between
anti-IL-4 mAb and rat IgG treated animals (Fig. 7B).
Discussion
In this work, we describe an experimental model for the
evaluation of the immunomodulatory effects of different isolates of
L. braziliensis that result in distinct disease manifestations. Using
this model, we show that immunomodulation by IL-4 contributes
to the different disease outcomes observed upon infection with
different L. braziliensis isolates.
Upon inoculation of BALB/c mice with L. braziliensis isolates
LTCP393(R) and LTCP15171(S) we observed clearly two distinct
patterns of disease development in the mice. The increased severity
of the disease caused in mice by the resistant parasites inoculation
was due to both, higher inflammation and increased parasite
burdens that could be observed only at later times post-infection.
In models of L. major infection, it is clearly established that the
type of inflammatory infiltrate may interfere with the infection
outcome. CD4+ and CD8+ T cells are important in inducing
protection via Th1 responses [5–9,37], while neutrophils may act
as a vehicle for silent entry of L. major into macrophages, favoring
parasite survival [38,39]. However, due to few studies concerning
about this issue, the importance of each cellular population in L.
braziliensis infection remains unknown.
Therefore, we analyzed the possible roles of cell populations in
inflammatory infiltrate for L.braziliensis disease outcomes, via
inoculation of LTCP393(R) or LTCP15171(S) L. braziliensis
isolates. Even presenting different disease manifestations, in both
groups, the inflammatory infiltrates were composed mainly by
CD4+ T lymphocytes and neutrophils. We found differences in the
number of cells in some infection time points, however, the
frequency of each cell population thus varied following the same
pattern in both groups. We observed that all the cell populations
analyzed increased or decreased following the same pattern in
both groups, according to parasite load. Additionally, no specific
cell population was altered differentially between the groups
throughout infection, showing no contribution of any specific cell
population in the disease outcomes observed in our model.
However, our results provide the first evidence that
CD4+CD25+FoxP3+ regulatory T cells (Treg), which have the
capacity to suppress Th1 effector responses and favor Leishmania
survival [40–45], are recruited to the infection sites in L.
braziliensis-infected mice.
The differences in the disease outcomes in our experimental
model could be due to differences in the induction of specific T cell
responses to the parasites of the distinct isolates. For this purpose,
we analyzed the production of Th1 cytokines, related to protection
to cutaneous leishmaniasis [7,9,16,17,46–49], and Th2 and Treg
cytokines, related to susceptibility in murine models of cutaneous
leishmaniasis [50,11,13], the two last of which have their role
poorly characterized in L. braziliensis infection.
In our model, the difference in disease outcomes was not due to
differential induction of Th1 responses by the isolates, since IFN-c
production in both groups was similar throughout the infection.
Also, IL-10 and TGF-b were expressed similarly in the lesions
throughout the critical points of infection, thus discarding the
possibility of any strong interference of differential Treg activity in
the lesion site could be determinant for the disease outcomes.
Therefore, during the later phases of infection, IL-10 production
increased in lymph node cultures from mice infected with both
isolates, mainly in LTCP393(R)-inoculated animals. Since this
increase occurred only when the lesions were healing or healed, we
believe that it may reflect the homeostatic control of the pro-
inflammatory responses, especially in LTCP393(R)-inoculated
mice, that presented a more robust inflammatory response at this
time point. On the other hand, increased IL-10 production may
also be responsible for the increase in the number of parasites in
the lymph nodes during the later phases of infection. Moura et al.
[32] also demonstrated an increase in the number of parasites in
lymph nodes of L. braziliensis-infected BALB/c mice in which
lesions were cured. It has been shown that IL-10 suppresses
effector responses, preventing sterile cure which confers immunity
to re-infection with L. major [12]. The ability of IL-10 to control
parasite numbers may also be important in maintaining immunity
to L. braziliensis; however, it could also represent an evolutionary
success of L. braziliensis parasites in maintaining a transmissible
reservoir in the host without causing disease.
Figure 5. Cytokines and enzymes mRNA expression in the ears
from LTCP393(R) and LTCP15171(S)-inoculated mice. The
animals were inoculated with 16106 stationary phase L. braziliensis
promastigotes, isolates LTCP393(R) (black bars) or LTCP15171(S) (white
bars). mRNA was extracted from the ears at 3, 5, 7 and 12 weeks post
infection, and the specific mRNAs for IFN-c (A), IL-4 (B), IL-10 (C), TGF-b
(D), TNF-a (E), iNOS (F) and Arg I(G) were detected by real time RT PCR.
The specific molecules mRNA expression was normalized based in the
endogenous expression of the mRNAm for b-actin. Results are listed as
the mean of expression in the ears of infected animals in relation to ears
of uninfected ones 6 standard error of mean, and are representative of
3 independent experiments. *p,0,05.
doi:10.1371/journal.pntd.0000965.g005
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TNF-a expression was also characterized, but this is a cytokine
that suffers posttranscriptional regulation, through binding of
proteins to a region called adenine urenine rich element (ARE),
present in TNF-a mRNA transcripts [51], and a better
characterization is needed to establish its role. However, in our
case, although TNF-a is related to protection against infection
[9,48,16], our finding of increased TNF-a mRNA expression in
lesions of LTCP393(R)-inoculated mice five weeks post-infection,
may be associated to Th2 responses. In the skin, keratinocytes may
produce TSLP, that up-regulates OX40L expression in dendritic
cells, which in turn drives differentiation of Th2 cells that produce
IL-4, IL-5, IL-13 and TNF-a [52–54]. The role of cytokines
produced by keratinocytes in L. braziliensis infection is an important
issue that must be investigated in future works.
In fact, the most striking difference we found between mice
infected with the resistant or susceptible isolates was in Th2
responses. IL-4, lesion size and parasite load dramatically
increased concomitantly in LTCP393(R)-inoculated mice com-
pared to LTCP15171(S)-inoculated animals. Also, IL-4 neutrali-
zation dropped lesion size and parasite loads in lesions of
LTCP393(R)-inoculated mice to the same levels found in
LTCP15171(S)-inoculated animals, while had no effect in the last
ones. This showed that induction of IL-4 production by
LTCP393(R) was responsible for the differences in lesion
development, susceptibility to parasite replication and disease
persistence between mice infected with the different isolates.
It would be expected that IL-4 neutralization led to higher IFN-
c production, increasing parasite killing. Therefore, we did not
observe any increase in IFN-c production upon IL-4 neutraliza-
tion (data not shown). In L. major infection, different grades of
resistance to infection could be seen in mice that produce similar
levels of IFN-c but varying levels of IL-4, suggesting that the
magnitude of the IL-4 response determines the severity of disease
more than IFN-c [55]. Also in patients infected with L. braziliensis,
the concomitant production of IL-4 together with IFN-c is
observed, and it has been proposed that it favors parasite survival
Figure 6. Anti-IL-4 mAb treatment reduces lesion thickness in LTCP393(R)-inoculated BALB/c mice. The animals were inoculated with
16106 L. braziliensis stationary phase promastigotes, isolates (A) LTCP393(R) or (B) LTCP15171(S), in the right ear dermis, treated with anti-IL-4
monoclonal antibody (black signs) or rat IgG (white signs), and the course of lesion development was monitored for 7 weeks. Lesion thickness was
determined as the difference between the infected ear and the contralateral one, noninfected. Results are expressed as mean 6 standard error of
mean, and are representative of 2 independent experiments. *p,0,05.
doi:10.1371/journal.pntd.0000965.g006
Figure 7. Anti-IL-4 mAb treatment reduces parasite loads in LTCP393(R)-inoculated BALB/c mice lesions. The animals were inoculated
at right ear dermis with 16106 stationary phase promastigotes of L. braziliensis, isolates LTCP393(R) (black bars) or LTCP15171(S) (white bars), treated
with anti-IL-4 monoclonal antibody (hatched bars) or rat IgG (full bars), and the parasite load estimated at 7 weeks post infection in the ears (A) and
draining lymph nodes (B). Results are expressed as mean 6 standard error of mean, and are representative of 2 independent experiments. Statistical
analysis: ANOVA and Tukey multiple comparision test. *p,0,05.
doi:10.1371/journal.pntd.0000965.g007
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and impairs spontaneous lesion healing. [56]. Likewise, even
though both isolates induce similar levels of IFN-c production,
experimental infection with the LTCP393(R) L. braziliensis isolate
induces production of higher levels of IL-4, which favors the
survival of this parasite and increases disease severity.
IL-4 is a potent activator of the enzyme arginase I (Arg I), which
competes with iNOS for L-arginine that is used for the synthesis of
NO, in macrophages. By consuming L-arginine, Arg I decreases
the availability of this substrate for iNOS, resulting in diminished
production of NO, and inhibition of inflammation [57].
Therefore, there is not a reciprocal inhibition between the
enzymes, and iNOS and Arg I can be concomitantly expressed
in macrophages at the mRNA and protein levels upon stimulation
[58,59]. Especially in a microenvironment where Th1 and Th2
responses are taking place at the same time, that is the case in
LTCP393(R)-inoculated mice, this feature occurs, as we showed.
Despite expressing the same levels of iNOS than LTCP15171(S)-
inoculated mice, the increased Arg I expression in LTCP393(R)-
inoculated mice suggests that increased IL-4 production in these
animals leads to increases in Arg I in the macrophages, resulting in
decreased production of NO, favoring parasite survival, which
results in a more severe disease. In lymph nodes, however, IL-4
seems not to interfere in the parasite elimination as in the lesions,
since high levels of IL-4 in LTCP393(R)-infected mice did not
result in increased parasite load (Fig. 2). Similarly, IL-4 depletion
did not result in significant parasite reduction in the organ. These
data show that the control of parasite growth and/or parasite
elimination in the periphery is distinct than that of lymphoid
organs. We do not know the mechanisms by which this feature
occurs, although it is possible that IL-10 could be involved. Also,
APCs as dendritic cells and macrophages, are able to kill the
parasites in the dependence of the microenvironment [60,61]. In
peripheral sites, these cells act mainly as ‘‘killer cells’’, while, upon
migration to lymphoid organs, they change their profile to
‘‘antigen presenting cells’’ [62–64].
In conclusion, our model allowed us to suggest that in addition
to intrinsic resistance to drugs and NO, the immunomodulation
towards Th2 response induced by certain parasite strains may
account for more severe lesions, increased parasite burdens, and
increased length of disease. We may ultimately propose that even
in the presence of IFN-c, IL-4 production increases arginase I
expression and impairs the parasite killing in lesion site. This
characteristic of some parasite isolates can be considered a
susceptibility factor for L. braziliensis infection. The models of
infection described here will be useful in the identification of
immunological targets to control L. braziliensis infection.
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